Trial Profile
Pharmacokinetics of antithymocyte globulins in patients with hematologic malignancies and undergoing allogeneic hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2015
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Graft-versus-host disease; Transplant rejection
- Focus Pharmacokinetics
- 25 May 2015 New trial record